View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Dentsply Sirona to Participate in Upcoming Investor Conferences

Dentsply Sirona to Participate in Upcoming Investor Conferences CHARLOTTE, N.C., May 08, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences. Bank of America 2024 Health Care Conference on May 15, 2024, at 9:20 am PT (12:20 pm ET)Stifel 2024 Jaws and Paws Conference on May 29, 2024, at 12:40 pm ET Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at About Dentsp...

 PRESS RELEASE

Dentsply Sirona Reports First Quarter 2024 Results

Dentsply Sirona Reports First Quarter 2024 Results Net sales of $953 million decreased (2.6%), organic sales decreased (1.9%)GAAP gross margin of 53.1%, GAAP net income of $18 million or $0.09 per shareAdjusted EBITDA margin of 16.8%, adjusted EPS of $0.42Maintaining FY24 outlook for organic sales and adjusted EPS, trending towards the low-end of both ranges; reported sales adjusted for additional foreign currency impactCompany expects to repurchase up to $150 million of its common stock in Q2 2024 CHARLOTTE, N.C, May 02, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” o...

MSCI Inc: 1 director

A director at MSCI Inc sold 9,000 shares at 471.689USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

 PRESS RELEASE

Dentsply Sirona to Host First Quarter Conference Call on May 2nd

Dentsply Sirona to Host First Quarter Conference Call on May 2nd CHARLOTTE, N.C., April 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, May 2, 2024, at 8:30 am ET to review its first quarter financial results. A presentation related to the call will be available on the Investors section of the Company’s website at Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company’s we...

Amgen Inc. - December 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Amgen Inc.: Near-term focus on pipeline execution, integration of Hori...

Our credit view of this issuer reflects its high profit margins and strong cash flow, constrained by unresolved IRS tax disputes

Moody's announces completion of a periodic review of ratings of Amgen ...

Moody's Ratings has completed a periodic review of the ratings of Amgen Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 7 March 2024 in which Moody's reassessed the appropriateness of the ratings in the context of the relevant...

Valens Research
  • Valens Research

MSCI - Valens Credit Report - 2024 03 05

Credit markets are accurately stating MSCI's credit risk with a YTW of 5.693% relative to an Intrinsic YTW of 5.553% and an Intrinsic CDS of 123bps. Meanwhile, Moody's is overstating the firm's fundamental credit risk, with its speculative Ba1 credit rating two notches below Valens' IG4 (Baa2) credit rating.

 PRESS RELEASE

Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board ...

Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board of Directors CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Eric K. Brandt, who has served as a Director on the Company’s Board of Directors (the “Board”) for nearly twenty years and as Chairman of the Board for six years, has informed the Board of his intention to retire at the May 2024 annual meeting and that he will not be standing for re-election. Mr. Brandt commented, “As I think back on the past two decades and all ...

 PRESS RELEASE

Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Pro...

Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend FY23 net sales of $3,965 million increased 1.1%, organic sales increased 2.2%FY23 GAAP net income (loss) of ($132) million or ($0.62) per share, adjusted EPS of $1.83Q4 net sales of $1,012 million increased 2.9%, organic sales increased 1.9%Q4 GAAP net income of $67 million or $0.32 per share, adjusted EPS of $0.44FY24 outlook: organic sales flat to up 1.5%; adjusted EPS of $2.00 to $2.10 CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Si...

 PRESS RELEASE

Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference C...

Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference Call on February 29th CHARLOTTE, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 29, 2024, at 8:30 am ET to review its fourth quarter and full year 2023 financial results. A presentation related to the call will be available on the Investors section of the Company’s website at .  Conference Call / Webcast Information A live webcast will be a...

 PRESS RELEASE

Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provi...

Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results CHARLOTTE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET). As part of the conference, the Company is providing an update on its 2023 full year anticipated financial results, with net sales expected to be at or above the high end of the Company’s previously provided outlook range of $...

 PRESS RELEASE

Dentsply Sirona to Present at the 42nd Annual J.P. Morgan Healthcare C...

Dentsply Sirona to Present at the 42nd Annual J.P. Morgan Healthcare Conference Charlotte, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET). Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at About Dentsp...

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2023 12 27

Valens Credit Research team highlights MSCI, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

 PRESS RELEASE

Dentsply Sirona Declares Quarterly Cash Dividend

Dentsply Sirona Declares Quarterly Cash Dividend CHARLOTTE, N.C., Dec. 21, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.14 per share of common stock, an indicated annual rate of $0.56 per share. The dividend is payable on January 12, 2024, to holders of record as of December 29, 2023. About Dentsply Sirona Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service t...

Valens Research
  • Valens Research

MSCI - Valens Credit Report - 2023 12 19

Credit markets are overstating MSCI's credit risk with a YTW of 6.013% relative to an Intrinsic YTW of 5.143% and an Intrinsic CDS of 92bps. Meanwhile, Moody's is overstating the firm's fundamental credit risk, with its speculative Ba1 credit rating two notches below Valens' IG4 (Baa2) credit rating. Incentives Dictate Behavior™ analysis highlights mostly positive signals for credit holders. MSCI's compensation metrics incentivizes management to improve all three value drivers: margins, revenue...

Dentsply Sirona Inc.: Update to credit analysis

Our credit view of this issuer reflects its moderate financial leverage and its strong market position in the dental device industry, against its high reliance on distributors.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch